DIAGNOSTICS DEFINING THERAPY
LIVE

Serial Number

79259148

Owner

SpeeDx Pty Ltd

Attorney

Joi A. White

Filing Date

Dec 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DIAGNOSTICS DEFINING THERAPY Trademark

Serial Number: 79259148 • Registration: 6039262

DIAGNOSTICS DEFINING THERAPY is a trademark filed by SpeeDx Pty Ltd on December 21, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SpeeDx Pty Ltd (21 trademarks)

Suite G16, National Innovation Centre,

Entity Type: 82

Trademark Details

Filing Date

December 21, 2018

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring

Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services

Surgical, medical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy

Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, and scientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 28, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 8, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2022 REAP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 13, 2021 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 31, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2020 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 19, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 19, 2019 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2019 TROA
REFUSAL PROCESSED BY IB
Jul 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 4, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 1, 2019 MAFR
ASSIGNED TO EXAMINER
May 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 23, 2019 REPR